Discovery of BIIB042, a potent, selective, and orally bioavailable γ-secretase modulator

…, T Talreja, Z Xin, JH Cuervo, G Kumaravel…

Index: Peng, Hairuo; Talreja, Tina; Xin, Zhili; Cuervo, J. Hernan; Kumaravel, Gnanasambandam; Humora, Michael J.; Xu, Lin; Rohde, Ellen; Gan, Lawrence; Jung, Mi-Young; Shackett, Melanie N.; Chollate, Sowmya; Dunah, Anthone W.; Snodgrass-Belt, Pamela A.; Arnold, H. Moore; Taveras, Arthur G.; Rhodes, Kenneth J.; Scannevin, Robert H. ACS Medicinal Chemistry Letters, 2011 , vol. 2, # 10 p. 786 - 791

Full Text: HTML

Citation Number: 12

Abstract

We have investigated a novel series of acid-derived γ-secretase modulators as a potential treatment of Alzheimer's disease. Optimization based on cellular potency and brain pharmacodynamics after oral dosing led to the discovery of 10a (BIIB042). Compound 10a is a potent γ-secretase modulator, which lowered Aβ42, increased Aβ38, but had little to no effect on Aβ40 levels both in vitro and in vivo. In addition, compound 10a did not affect ...

Related Articles:

Discovery of 4-aminomethylphenylacetic acids as γ-secretase modulators via a scaffold design approach

[Xin, Zhili; Peng, Hairuo; Zhang, Andrew; Talreja, Tina; Kumaravel, Gnanasambandam; Xu, Lin; Rohde, Ellen; Jung, Mi-Yong; Shackett, Melanie N.; Kocisko, David; Chollate, Sowmya; Dunah, Anthone W.; Snodgrass-Belt, Pamela A.; Moore Arnold; Taveras, Arthur G.; Rhodes, Kenneth J.; Scannevin, Robert H. Bioorganic and Medicinal Chemistry Letters, 2011 , vol. 21, # 24 p. 7277 - 7280]

Discovery of 4-aminomethylphenylacetic acids as γ-secretase modulators via a scaffold design approach

[Xin, Zhili; Peng, Hairuo; Zhang, Andrew; Talreja, Tina; Kumaravel, Gnanasambandam; Xu, Lin; Rohde, Ellen; Jung, Mi-Yong; Shackett, Melanie N.; Kocisko, David; Chollate, Sowmya; Dunah, Anthone W.; Snodgrass-Belt, Pamela A.; Moore Arnold; Taveras, Arthur G.; Rhodes, Kenneth J.; Scannevin, Robert H. Bioorganic and Medicinal Chemistry Letters, 2011 , vol. 21, # 24 p. 7277 - 7280]

More Articles...